The One Fund Boston, MGH and Massachusetts Eye and Ear Infirmary are creating the One Fund Center, a collaboration that will offer ongoing care to those affected by the often invisible, yet persistent, injuries sustained in the Boston Marathon bombings.. Read more.
9/16/14: Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas A study by MGH investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine point-of-care CD4 testing at the time of HIV diagnosis could be cost effective in countries where health care and other resources are severely limited.
9/03/14: Digital mammography system developed at Mass. General Hospital receives FDA approval A digital mammography system developed based on concepts originally tested at MGH has been approved by the U.S. Food and Drug Administration.
9/03/14: One Fund Center launches in September to offer ongoing care for those affected by the marathon bombings The One Fund Boston, MGH and Massachusetts Eye and Ear Infirmary today announced the creation of the One Fund Center, a collaboration that will offer ongoing care to those affected by the often invisible, yet persistent, injuries sustained in the Boston Marathon bombings.
9/02/14: Cannabis withdrawal symptoms common among adolescents treated for substance use disorder Although cannabis – commonly known as marijuana – is broadly believed to be nonaddictive, a study by MGH investigators found that 40 percent of cannabis-using adolescents receiving outpatient treatment for substance use disorder experienced symptoms of withdrawal, which are considered a hallmark of drug dependence.
8/28/14: Circulating tumor cell clusters more likely to cause metastasis than single cells Circulating tumor cell clusters – clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream – appear to be much more likely to cause metastasis than are single CTCs, according to a study from investigators at the MGH Cancer Center.
Newsletters & Publications
Hotline Each week, MGH Hotline reports important news within the Massachusetts General Hospital community featuring employees and initiatives that focus on bettering the future of clinical care, research and training.
Proto Proto, a magazine that reaches 75,000 thought leaders nationwide, stakes its ground on medicine's leading edge, reporting back from the frontiers of research and practice—exploring breakthroughs, dissecting controversies and opening a forum for informed debate.
Mass General Magazine Mass General Magazine takes you into the heart of the institution, describing ways in which Mass General is leading the way in educating physicians, nurses and other healthcare professionals; in improving the health of local and distant communities; and in establishing best practices and health policy.
09/05/2014: 'Close to a cure' - Amesbury brothers with diabetes take part in bionic pancreas trials
coverage of participants in trial co-led by MGH investigator Steven Russell
09/05/2014: Child’s trauma diagnosis defended
The Boston Globe
mentions testimony by MGH physician Alice Newton
09/05/2014: Cancer immunotherapy on the cusp
quotes MGH physician Keith Flaherty
09/05/2014: Leap in aid to disabled kids reflects crushing gaps in welfare
The Boston Globe
article written by MGHfC physician James Perrin
09/05/2014: Marijuana Study Raises New Concerns About Pot Addiction In Teens
The Huffington Post
coverage of study led by MGH psychologist John Kelly
09/05/2014: PPD improves process to test drugs in patients with depression
Triangle Business Journal (Raleigh, N.C.)
mentions technique developed by MGH physician Maurizio Fava
09/05/2014: FDA Approves GE’s New Breast 3D Imaging Technology, SenoClaire
Radiation Therapy News
quotes MGH physician Daniel Kopans